Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleNeurointervention

Feasibility of Using Hyperosmolar Mannitol as a Liquid Tumor Embolization Agent

Lei Feng, Beverly A. Kienitz, Carolyn Matsumoto, Jeffrey Bruce, Michael Sisti, Hoang Duong and John Pile-Spellman
American Journal of Neuroradiology June 2005, 26 (6) 1405-1412;
Lei Feng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverly A. Kienitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Matsumoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Bruce
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Sisti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hoang Duong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Pile-Spellman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 1.

    Cytotoxicity of mannitol on endothelial and meningioma cells.

    A, HUVECs stained with LIVE/DEAD kit. After treatment with 1200 mOsm for 15 minutes, almost all endothelial cells shrank and lost their typical cobblestone morphology. Many of them detached from the culture plate. Orange nuclei depicting dead cells can be seen on the remaining cells.

    B, Meningioma cells stained with LIVE/DEAD kit. Similar cytotoxic effect is seen in the meningioma culture after incubation with 600 mOsm for 1 hour.

  • Fig 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 2.

    Dose- and time-dependent cytotoxic effect of mannitol on endothelial cells. The kill rates of endothelial cells by various concentrations of mannitol after 15- (white bars) and 30-minute (gray or hatched bars) incubation are shown in this graph. NS, normal saline; M300, 300 mOsm mannitol; M600, 600 mOsm mannitol; M900, 900 mOSm mannitol; M1200, 1200 mOsm mannitol; M/I, 25% mannitol and iohexol mixed at 2 : 1 ratio; I, iohexol alone. A small portion of cell death (8–10 ± 1%) is caused by <900 mOsm mannitol after 15 minutes of incubation. As much as 17 ± 2% of endothelial cells die after 15 minutes of incubation with 1200 mOsm mannitol. When incubated for 30 minutes, the cell death rates are significantly higher for all concentrations of mannitol (P < .01 by t test). Mannitol and iohexol mixture has the highest cell death rate, at 52 ± 1%. Normal saline and iohexol alone have little effect on survival of endothelial cells. The error bars depict standard errors.

  • Fig 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 3.

    Cytotoxic effect of mannitol on five meningioma cell lines. The average kill rates of five meningioma cell lines by 300 mOsm (M300) of mannitol, 600 mOsm (M600), of mannitol and mannitol/iohexol 2:1 mixture (M/I) are shown in this graph. The cell death rates are 22 ± 2% and 23 ± 3% for 600 mOsm of mannitol and mannitol and iohexol mixture, respectively. Little cytotoxic effect is seen for normalsaline (NS) and iohexol alone (I).

  • Fig 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 4.

    Apoptotic and lytic cell death in meningioma cells. After 1-hour treatment of meningioma cell lines with 900 mOsm of mannitol (A and B), normal saline (C), and 900 mOsm hypertonic saline (D), the cells are reacted with TUNEL reagents to detect programmed cell death. A rapidly proliferating meningioma cell line (A) demonstrates frequent apoptotic cells that are stained brown by the TUNEL reagents. There are very few ghosts of dissolved cells, which are marked by the arrows. More lytic (arrows) cell death than apoptotic cell death (brown cells) occurs in a slow-growing meningioma line (B). Normal saline and hypertonic saline controls reveal no significant cell death.

  • Fig 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 5.

    Mannitol embolization of a large frontal meningioma.

    A, Tumor vessels coming off the left middle meningeal artery are shown by this early arterial phase of left external carotid angiogram.

    B, The capillary phase of the same angiogram reveals the typical tumor blush in the meningioma.

    C, Postembolization angiogram of the left external carotid artery shows lack of filling of the tumor vessels in the early arterial phase.

    D, Most of the tumor blush has been eliminated and contrast stagnation is seen in one of the middle meningeal branch in the delayed phase.

  • Fig 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 6.

    MR imaging changes after embolization.

    A, Before embolization, T1-weighted axial image of the brain with gadolinium reveals a large left parietal extraaxial homogenously enhancing tumor, consistent with meningioma.

    B, T2-weighted axial image demonstrating significant mass effect and parenchymal edema.

    C, After embolization, only the periphery of the tumor shows enhancement on this postcontrast T1 axial image. The center of the tumor becomes necrotic.

Tables

  • Figures
  • Patients with meningioma treated with preoperative embolization

    AgeSexLocationSize (cm)Interval to surgery (day)EBL (cc)Tumor necrosis
    169MFrontal71400Yes
    259FPetrous52500Yes
    347FConvexity66800Yes
    472FSphenoid61250No
    577FConvexity71NRNo
    645FConvexity61500Yes
    754FConvexity123200Yes
    857FFalcineNR2200No
    974FTentorium83650No
    1044FSphenoidNR1500Yes
    1162FPetrous51NRNo
    1222FConvexity81800Yes
    1380FFrontal6.54100No
    1467FTemporal41200No
    1530FFalcine61500yes
    1630FFalcine6NRNRNR
    1761FSphenoid5NRNRNR
    1869FConvexity71100No
    1955MClival5NS
    2061FPetrous3NS
    2184MSphenoidNRNS
    2268MSphenoid7NS
    2379FConvexityNRNS
    • Note.—NR indicates not recorded; NS, no surgery; and EBL, estimated blood loss.

PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 26 (6)
American Journal of Neuroradiology
Vol. 26, Issue 6
1 Jun 2005
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility of Using Hyperosmolar Mannitol as a Liquid Tumor Embolization Agent
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Lei Feng, Beverly A. Kienitz, Carolyn Matsumoto, Jeffrey Bruce, Michael Sisti, Hoang Duong, John Pile-Spellman
Feasibility of Using Hyperosmolar Mannitol as a Liquid Tumor Embolization Agent
American Journal of Neuroradiology Jun 2005, 26 (6) 1405-1412;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Feasibility of Using Hyperosmolar Mannitol as a Liquid Tumor Embolization Agent
Lei Feng, Beverly A. Kienitz, Carolyn Matsumoto, Jeffrey Bruce, Michael Sisti, Hoang Duong, John Pile-Spellman
American Journal of Neuroradiology Jun 2005, 26 (6) 1405-1412;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Preoperative Embolization of Intracranial Meningiomas: Efficacy, Technical Considerations, and Complications
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Rescue Reentry in Carotid Near-Occlusion
  • Contour Neurovascular System: Five Year Follow Up
  • Effect of SARS-CoV2 on Endovascular Thrombectomy
Show more Neurointervention

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire